Legend Biotech (LEGN) Exchange Rate Effect (2019 - 2025)
Legend Biotech (LEGN) posted Exchange Rate Effect of -$2.7 million for Q4 2025, down 195.17% on a QoQ basis from $2.8 million in Q3 2025, and down 17.39% year-over-year from -$3.3 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Exchange Rate Effect data on file, last reported at -$2.7 million in Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 17.39% year-over-year to -$2.7 million; the TTM figure through Dec 2025 stood at $6.0 million (up 383.32% YoY), while the FY2025 annual figure was $6.1 million, up 390.48% from the prior year.
- Exchange Rate Effect eased to -$2.7 million in Q4 2025, from $2.8 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $4.4 million in Q2 2025 and bottomed at -$2.7 million in Q4 2025.
- A 5-year average of $103700.0 and a median of $9500.0 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect slumped 23640.0% — and 2025, when it surged 49244.44%.
- Year by year, Exchange Rate Effect stood at $78000.0 in 2021, then sank by 1521.79% to -$1.1 million in 2022, then jumped by 231.11% to $1.5 million in 2023, then tumbled by 258.18% to -$2.3 million in 2024, then slipped by 17.39% to -$2.7 million in 2025.
- The last three Exchange Rate Effect figures came in at -$2.7 million (Q4 2025), $2.8 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.70 Mn |
| Dec 31, 2025 | -2.70 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Dec 31, 2024 | -2.30 Mn |
| Sep 30, 2024 | 524,000.00 |
| Sep 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Dec 31, 2023 | 1.45 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | -784,000.00 |
| Sep 30, 2023 | -784,000.00 |
| Jun 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 2.37 Mn |
| Mar 31, 2023 | -2.35 Mn |
| Mar 31, 2023 | -2.35 Mn |
| Dec 31, 2022 | -1.11 Mn |
| Dec 31, 2022 | -1.11 Mn |
| Sep 30, 2022 | -547,000.00 |
| Sep 30, 2022 | -547,000.00 |
| Jun 30, 2022 | -864,000.00 |
| Jun 30, 2022 | -864,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 78,000.00 |
| Dec 31, 2021 | 78,000.00 |
| Sep 30, 2021 | -759,000.00 |
| Sep 30, 2021 | -759,000.00 |
| Jun 30, 2021 | 378,000.00 |
| Jun 30, 2021 | 378,000.00 |
| Mar 31, 2021 | 337,000.00 |
| Mar 31, 2021 | 337,000.00 |
| Dec 31, 2020 | 434,000.00 |
| Dec 31, 2020 | 434,000.00 |
| Sep 30, 2020 | 325,000.00 |
| Sep 30, 2020 | 325,000.00 |
| Jun 30, 2020 | -112,000.00 |
| Jun 30, 2020 | -112,000.00 |
| Mar 31, 2020 | -27,000.00 |
| Mar 31, 2020 | -27,000.00 |
| Dec 31, 2019 | 304,000.00 |
| Dec 31, 2019 | 304,000.00 |
| Sep 30, 2019 | -44,000.00 |
| Sep 30, 2019 | -44,000.00 |
| Jun 30, 2019 | -16,000.00 |
| Jun 30, 2019 | -16,000.00 |